Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 4,015 | 2,926 | 2,738 | 2,910 |
| Gross Profit | N/A | 4,015 | 2,926 | 2,738 | 2,910 |
| Operating Expenses | 60,138 | 50,493 | 47,562 | 85,708 | 53,432 |
| Operating Income | -60,138 | -46,478 | -44,636 | -82,970 | -50,522 |
| Other Income | 2,681 | 3,081 | 2,996 | 2,721 | 3,422 |
| Pre-tax Income | -57,457 | -43,397 | -41,640 | -80,249 | -47,100 |
| Net Income Continuous | -57,457 | -43,397 | -41,640 | -80,249 | -47,100 |
| Net Income | $-57,457 | $-43,397 | $-41,640 | $-80,249 | $-47,100 |
| EPS Basic Total Ops | -0.65 | -0.50 | -0.52 | -1.11 | -0.78 |
| EPS Basic Continuous Ops | -0.65 | -0.50 | -0.52 | -1.10 | -0.78 |
| EPS Diluted Total Ops | -0.65 | -0.50 | -0.52 | -1.11 | -0.78 |
| EPS Diluted Continuous Ops | -0.65 | -0.50 | -0.52 | -1.10 | -0.78 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.50 | -0.52 | -0.84 | -0.78 |
| EBITDA(a) | $-60,221 | $-46,963 | $-44,728 | $-82,911 | $-51,424 |